164 related articles for article (PubMed ID: 31441359)
21. ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy.
Rebagay G; Yan S; Liu C; Cheung NK
Front Oncol; 2012; 2():34. PubMed ID: 22655270
[TBL] [Abstract][Full Text] [Related]
22. Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies.
Daneshmanesh AH; Porwit A; Hojjat-Farsangi M; Jeddi-Tehrani M; Tamm KP; Grandér D; Lehmann S; Norin S; Shokri F; Rabbani H; Mellstedt H; Österborg A
Leuk Lymphoma; 2013 Apr; 54(4):843-50. PubMed ID: 22988987
[TBL] [Abstract][Full Text] [Related]
23. Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility.
Peng H; Nerreter T; Chang J; Qi J; Li X; Karunadharma P; Martinez GJ; Fallahi M; Soden J; Freeth J; Beerli RR; Grawunder U; Hudecek M; Rader C
J Mol Biol; 2017 Sep; 429(19):2954-2973. PubMed ID: 28818634
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of rat Ror1 and Ror2 genes in silico.
Katoh M; Katoh M
Int J Mol Med; 2005 Mar; 15(3):533-8. PubMed ID: 15702250
[TBL] [Abstract][Full Text] [Related]
25. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.
Endo M; Doi R; Nishita M; Minami Y
J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498
[TBL] [Abstract][Full Text] [Related]
26. Novel Antibody Drug Conjugates Targeting Tumor-Associated Receptor Tyrosine Kinase ROR2 by Functional Screening of Fully Human Antibody Libraries Using Transpo-mAb Display on Progenitor B Cells.
Hellmann I; Waldmeier L; Bannwarth-Escher MC; Maslova K; Wolter FI; Grawunder U; Beerli RR
Front Immunol; 2018; 9():2490. PubMed ID: 30450096
[TBL] [Abstract][Full Text] [Related]
27. ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.
Liu D; Gunther K; Enriquez LA; Daniels B; O'Mara TA; Tang K; Spurdle AB; Ford CE
Sci Rep; 2020 Aug; 10(1):13906. PubMed ID: 32807831
[TBL] [Abstract][Full Text] [Related]
28. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.
Zhang S; Cui B; Lai H; Liu G; Ghia EM; Widhopf GF; Zhang Z; Wu CC; Chen L; Wu R; Schwab R; Carson DA; Kipps TJ
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17266-71. PubMed ID: 25411317
[TBL] [Abstract][Full Text] [Related]
29. Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer.
Henry CE; Llamosas E; Djordjevic A; Hacker NF; Ford CE
Oncogenesis; 2016 May; 5(5):e226. PubMed ID: 27239958
[TBL] [Abstract][Full Text] [Related]
30. Antiproliferative and Apoptotic Effects of Novel Anti-ROR1 Single-Chain Antibodies in Hematological Malignancies.
Aghebati-Maleki L; Younesi V; Baradaran B; Abdolalizadeh J; Motallebnezhad M; Nickho H; Shanehbandi D; Majidi J; Yousefi M
SLAS Discov; 2017 Apr; 22(4):408-417. PubMed ID: 28328317
[TBL] [Abstract][Full Text] [Related]
31. Advances in chimeric antigen receptor immunotherapy for neuroblastoma.
Heczey A; Louis CU
Discov Med; 2013 Dec; 16(90):287-94. PubMed ID: 24333408
[TBL] [Abstract][Full Text] [Related]
32. Differential subcellular localization of Ror tyrosine kinase receptors in cultured astrocytes.
Paganoni S; Anderson KL; Ferreira A
Glia; 2004 May; 46(4):456-66. PubMed ID: 15095375
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells.
Hojjat-Farsangi M; Ghaemimanesh F; Daneshmanesh AH; Bayat AA; Mahmoudian J; Jeddi-Tehrani M; Rabbani H; Mellstedt H
PLoS One; 2013; 8(4):e61167. PubMed ID: 23593420
[TBL] [Abstract][Full Text] [Related]
34. Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies.
Dave H; Anver MR; Butcher DO; Brown P; Khan J; Wayne AS; Baskar S; Rader C
PLoS One; 2012; 7(12):e52655. PubMed ID: 23285131
[TBL] [Abstract][Full Text] [Related]
35. Genetic interactions between Ror2 and Wnt9a, Ror1 and Wnt9a and Ror2 and Ror1: Phenotypic analysis of the limb skeleton and palate in compound mutants.
Weissenböck M; Latham R; Nishita M; Wolff LI; Ho HH; Minami Y; Hartmann C
Genes Cells; 2019 Apr; 24(4):307-317. PubMed ID: 30801848
[TBL] [Abstract][Full Text] [Related]
36. Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development.
Matsuda T; Nomi M; Ikeya M; Kani S; Oishi I; Terashima T; Takada S; Minami Y
Mech Dev; 2001 Jul; 105(1-2):153-6. PubMed ID: 11429290
[TBL] [Abstract][Full Text] [Related]
37. Essential role of Wnt5a-Ror1/Ror2 signaling in metanephric mesenchyme and ureteric bud formation.
Qi X; Okinaka Y; Nishita M; Minami Y
Genes Cells; 2016 Apr; 21(4):325-34. PubMed ID: 26840931
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of anti ROR1 single chain fragment variable antibodies using phage display technique.
Aghebati-Maleki L; Younesi V; Jadidi-Niaragh F; Baradaran B; Majidi J; Yousefi M
Hum Antibodies; 2017; 25(1-2):57-63. PubMed ID: 28128766
[TBL] [Abstract][Full Text] [Related]
39. [The Construction of ROR1 Targeting Chimeric Antigen Receptor Modified T Cells and Its Killing Effect for ROR1-positive Tumor Cells].
Chen Y; Mo ZM; Qin DY; Guo FC; Liao XL; Hu M; Chen Q; Wang YS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 50(2):145-151. PubMed ID: 31106530
[TBL] [Abstract][Full Text] [Related]
40. Analysis of ROR1 Protein Expression in Mice with Reconstituted Human Immune System Components.
Leung CS
J Immunol Res; 2018; 2018():2480931. PubMed ID: 29850623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
